0001637761-23-000038.txt : 20230109
0001637761-23-000038.hdr.sgml : 20230109
20230109191841
ACCESSION NUMBER: 0001637761-23-000038
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230105
FILED AS OF DATE: 20230109
DATE AS OF CHANGE: 20230109
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Winge John J.
CENTRAL INDEX KEY: 0001644531
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36905
FILM NUMBER: 23519409
MAIL ADDRESS:
STREET 1: C/O SEASPINE HOLDINGS CORPORATION
STREET 2: 2302 LA MIRADA DRIVE
CITY: VISTA
STATE: CA
ZIP: 92081
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SeaSpine Holdings Corp
CENTRAL INDEX KEY: 0001637761
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 473251758
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5770 ARMADA DRIVE
CITY: CARLSBAD
STATE: CA
ZIP: 92008
BUSINESS PHONE: (760) 727-8399
MAIL ADDRESS:
STREET 1: 5770 ARMADA DRIVE
CITY: CARLSBAD
STATE: CA
ZIP: 92008
4
1
wf-form4_167330990764168.xml
FORM 4
X0306
4
2023-01-05
1
0001637761
SeaSpine Holdings Corp
SPNE
0001644531
Winge John J.
C/O SEASPINE HOLDINGS CORPORATION
5770 ARMADA DR
CARLSBAD
CA
92008
0
1
0
0
Vice President, Sales
Common Stock
2023-01-05
4
D
0
90951
D
0
D
Restricted Stock Units
0.0
2023-01-05
4
D
0
14432
D
Common Stock
14432.0
0
D
Restricted Stock Units
2023-01-05
4
D
0
30248
D
Common Stock
30248.0
0
D
Employee Stock Option (Right to Buy)
15.68
2023-01-05
4
D
0
40000
D
2023-08-01
Common Stock
40000.0
0
D
Employee Stock Option (Right to Buy)
14.19
2023-01-05
4
D
0
59562
D
2024-01-27
Common Stock
59562.0
0
D
Employee Stock Option (Right to Buy)
18.24
2023-01-05
4
D
0
31118
D
2027-01-01
Common Stock
31118.0
0
D
Employee Stock Option (Right to Buy)
12.01
2023-01-05
4
D
0
48678
D
2028-01-01
Common Stock
48678.0
0
D
Employee Stock Option (Right to Buy)
9.93
2023-01-05
4
D
0
5342
D
2028-04-23
Common Stock
5342.0
0
D
Employee Stock Option (Right to Buy)
15.0
2023-01-05
4
D
0
18912
D
2030-02-28
Common Stock
18912.0
0
D
Disposed of pursuant to the Agreement and Plan of Merger by and among the issuer, SeaSpine Holdings Corporation, which became effective on January 5, 2023, in exchange for 37,862 Orthofix Medical Inc. ("Orthofix") ordinary shares having a market value of $22.76 per share at the effective time of the merger.
Each restricted stock unit represents a contingent right to receive one share of SeaSpine Holdings Corporation common stock.
The restricted stock units vest in three equal installments on each of January 28, 2022, 2023 and 2024.
These restricted stock units were assumed by Orthofix in the merger and replaced by 6,008 Orthofix restricted stock units.
The restricted stock units vest in three equal installments on each of February 28, 2023, 2024 and 2025.
These restricted stock units were assumed by Orthofix in the merger and replaced by 12,592 Orthofix restricted stock units.
The option vests as to 25% of the underlying shares on May 1, 2016 and the remaining 75% in twelve substantially equal quarterly installments thereafter.
This option was assumed by Orthofix in the merger and replaced with an option to purchase 16,652 shares of Orthofix at a price of $37.67 per share.
The option vests in sixteen substantially equal quarterly installments beginning on March 31, 2016.
This option was assumed by Orthofix in the merger and replaced with an option to purchase 24,795 shares of Orthofix at a price of $34.09 per share.
The option vests as to 25% of the underlying shares on January 1, 2020 and the remaining 75% in twelve substantially equal quarterly installments thereafter.
This option was assumed by Orthofix in the merger and replaced with an option to purchase 12,954 shares of Orthofix at a price of $43.82 per share.
The option vests as to 25% of the underlying shares on January 1, 2021 and the remaining 75% in twelve substantially equal quarterly installments thereafter.
This option was assumed by Orthofix in the merger and replaced with an option to purchase 20,264 shares of Orthofix at a price of $28.85 per share.
The option fully vested and became exercisable on June 21, 2020.
This option was assumed by Orthofix in the merger and replaced with an option to purchase 2,223 shares of Orthofix at a price of $23.86 per share.
The option vests as to 25% of the underlying shares on February 28, 2023 and the remaining 75% in twelve substantially equal quarterly installments thereafter.
This option was assumed by Orthofix in the merger and replaced with an option to purchase 7,873 shares of Orthofix at a price of $36.04 per share.
/s/Paul Benny, Attorney-in-Fact for John J. Winge
2023-01-09